|
INTS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.19759979710921E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.00699999999276E-05 |
| Normal-vs-Stage2 |
2.595900E-02 |
| Normal-vs-Stage3 |
2.963600E-02 |
| Normal-vs-Stage4 |
2.095000E-01 |
| Stage1-vs-Stage2 |
5.968800E-01 |
| Stage1-vs-Stage3 |
9.642400E-01 |
| Stage1-vs-Stage4 |
5.006200E-01 |
| Stage2-vs-Stage3 |
6.355200E-01 |
| Stage2-vs-Stage4 |
6.341600E-01 |
| Stage3-vs-Stage4 |
5.019600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.29829999476294E-09 |
| Normal-vs-AfricanAmerican |
1.742290E-02 |
| Normal-vs-Asian |
3.687800E-01 |
| Caucasian-vs-AfricanAmerican |
1.945700E-02 |
| Caucasian-vs-Asian |
5.630000E-01 |
| AfricanAmerican-vs-Asian |
9.375200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.19199999981667E-07 |
| Normal-vs-Female |
7.00890000038257E-07 |
| Male-vs-Female |
7.650100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.593600E-02 |
| Normal-vs-Extreme_Weight |
5.921400E-03 |
| Normal-vs-Obese |
1.001940E-04 |
| Normal-vs-Extreme_Obese |
2.119200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.724400E-01 |
| Normal_Weight-vs-Obese |
5.673600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.878800E-01 |
| Extreme_Weight-vs-Obese |
1.167970E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.962000E-01 |
| Obese-vs-Extreme_Obese |
6.912000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.382180E-03 |
| Normal-vs-Age(41-60Yrs) |
9.72650004982256E-09 |
| Normal-vs-Age(61-80Yrs) |
4.609500E-04 |
| Normal-vs-Age(81-100Yrs) |
7.728800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.248400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.821000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.838800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.300300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.304500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.066200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.43260001031587E-09 |
| Normal-VS-Type2 PRCC |
1.763790E-02 |
| Normal-VS-KIRP CIMP |
2.853600E-02 |
| Normal-VS-Unclassified PRCC |
1.355920E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.574200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.954240E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.106200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.363400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.846640E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.178600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.148300E-02 |
| Normal-vs-N1 |
1.955960E-02 |
| Normal-vs-N2 |
1.958000E-01 |
| N0-vs-N1 |
1.405960E-01 |
| N0-vs-N2 |
3.829400E-01 |
| N1-vs-N2 |
8.663400E-01 |
|
|
